Grandway SaviXin Life Sciences

Grandway SaviXin Life Sciences is a biotechnology company based in Suzhou, China, focused on the development of innovative vaccines for infectious diseases. The company operates as a joint venture between Grandway Healthcare, a clinical research organization, and SaviXin Biotech, a vaccine technology developer. Its core expertise lies in recombinant protein and mRNA vaccine platforms, which are designed to provide high-efficacy and scalable immunization solutions. The company's lead program is a recombinant protein vaccine for COVID-19 that has reached mid-to-late-stage clinical trials. By combining clinical trial management expertise with advanced molecular biology, Grandway SaviXin aims to rapidly respond to emerging public health threats.